On the other hand, CTNNB1 knockdown inhibits the Wnt/β-catenin signaling pathway and downregulates the expression of downstream genes, including axin 2, lymphoid enhancer-binding factor 1 (LEF1), and cyclin D1, thereby inhibiting tumor proliferation (36). Here, CTNNB1 is linked to neoplasm.